Company logo

Clemedi AG

Scientific research and development
Life Sciences
Dr. Sebastian Dümcke
Wagistr. 12
8952 Schlieren

Give the right antibiotic! Clemedi is developing in vitro diagnostic tests for infectious diseases, by uniting two novel technologies - Next-generation Sequencing and Machine learning. We will contribute to limiting deaths caused by antibiotic-resistant bacteria, projected to reach 10 million annually in 2050! Our products make the world a safer place through restricting the spread of antibiotic resistance and our diagnostic tests support doctors’ decision making. This benefits patients suffering from infectious diseases by facilitating a timely and targeted antibiotic therapy.We are looking for partners for clinical evaluation of our tuberculosis product as well as investors to finance the product through CE-IVD certification